FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers

被引：0
|
作者：
Nichetti, F. [1 ]
Rizzato, M. [2 ]
Bensi, M. [3 ]
Salani, F. [4 ]
Franza, A. [1 ]
Piva, V. [2 ]
Cerantola, R. [2 ]
Chiaravalli, M. [5 ]
Masi, G. [6 ]
Djaballah, S. Ahcene [2 ]
Barone, D.
Vivaldi, C. [6 ]
Bergamo, F. [2 ]
Rota, S. [1 ]
Di Bartolomeo, M. [7 ]
de Braud, F. [8 ]
Niger, M. [1 ]
Lonardi, S. [2 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy
[2] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Padua, Italy
[3] Univ Cattolica Sacro Cuore, Ctr Comprehens Canc, Fdn Policlin Univ Agostino Gemelli, Oncol Med,IRCCS, Rome, Italy
[4] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Comprehens Canc, Oncol Med, Rome, Italy
[6] Univ Pisa, Med Oncol Unit, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[7] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[8] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.331
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-275
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin
    He, Shengli
    Shen, Jie
    Sun, Xianjun
    Liu, Luming
    Dong, Jingcheng
    [J]. JOURNAL OF CHEMOTHERAPY, 2014, 26 (04) : 243 - 247
  • [2] FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
    Roussot, Nicolas
    Vincent, Julie
    Palmier, Remi
    Constantin, Guillaume
    Bengrine, Leila
    Fumet, Jean-David
    Ghiringhelli, Francois
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] The impact of second-line treatment after fist-line cisplatin plus gemcitabine in advanced biliary tract cancers: A mono-institutional retrospective study
    Gurreri, E.
    Chiaravalli, M.
    Bensi, M.
    Bagala, C.
    Di Stefano, B.
    Beccia, V.
    Spring, A.
    Monaca, F.
    Barone, D.
    Maratta, M.
    Tortora, G.
    Salvatore, L.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S302 - S302
  • [4] Second-line FOLFOX chemotherapy for advanced biliary tract cancer
    Brandi, Giovanni
    Frega, Giorgio
    Rizzo, Alessandro
    [J]. LANCET ONCOLOGY, 2021, 22 (07): : E285 - E285
  • [5] A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [6] A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. CHEMOTHERAPY, 2013, 59 (02): : 106 - 111
  • [7] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [8] FOLFIRI or FOLFOX in second line of advanced biliary tract cancer: A retrospective analysis
    Balarine, M.
    Felismino, T.
    Camandaroba, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S265 - S265
  • [9] Second-line therapies in advanced biliary tract cancers
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Borad, Mitesh J.
    Mahipal, Amit
    [J]. LANCET ONCOLOGY, 2020, 21 (01): : E29 - E41
  • [10] The impact of second-line treatment after fist-line cisplatin plus gemcitabine in advanced biliary tract cancers: A mono-institutional retrospective study.
    Chiaravalli, Marta
    Bensi, Maria
    Bagala, Cinzia
    Di Stefano, Brunella
    Beccia, Viria
    Spring, Alexia
    Gurreri, Enrico
    Monaca, Federico
    Barone, Diletta
    Maratta, Maria Grazia
    Tortora, Giampaolo
    Salvatore, Lisa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16180 - E16180
12345